The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Current Understanding of the Pathogenesis of Dengue Virus Infection
Open accessAbstract
The pathogenesis of dengue virus infection is attributed to complex interplay between virus, host genes and host immune response. Host factors such as antibody-dependent enhancement (ADE), memory cross-reactive T cells, anti-DENV NS1 antibodies, autoimmunity as well as genetic factors are major determinants of disease susceptibility. NS1 protein and anti-DENV NS1 antibodies were believed to be responsible for pathogenesis of severe dengue. The cytokine response of cross-reactive CD4+ T cells might be altered by the sequential infection with different DENV serotypes, leading to further elevation of pro-inflammatory cytokines contributing a detrimental immune response. Fcγ receptor-mediated antibody-dependent enhancement (ADE) results in release of cytokines from immune cells leading to vascular endothelial cell dysfunction and increased vascular permeability. Genomic variation of dengue virus and subgenomic flavivirus RNA (sfRNA) suppressing host immune response are viral determinants of disease severity. Dengue infection can lead to the generation of autoantibodies against DENV NS1antigen, DENV prM, and E proteins, which can cross-react with several self-antigens such as plasminogen, integrin, and platelet cells. Apart from viral factors, several host genetic factors and gene polymorphisms also have a role to play in pathogenesis of DENV infection. This review article highlights the various factors responsible for the pathogenesis of dengue and also highlights the recent advances in the field related to biomarkers which can be used in future for predicting severe disease outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global distribution and burden of dengue
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037 · cited 1×
“This arboviral disease is found to be endemic in more than 100 countries and around 96 million infected individuals are symptomatic with varying levels of severity [1, 2].”
Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632
Antibody-dependent enhancement of severe dengue disease in humans
Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G., Gordon, A., Balmaseda, A., & Harris, E. (2017) · Science · doi:10.1126/science.aan6836 · Cited by 1,205
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
Hadinegoro, S. R., Arredondo-García, J. L., Capeding, M. R., Deseda, C., Chotpitayasunondh, T., Dietze, R., Hj Muhammad Ismail, H. I., Reynales, H., Limkittikul, K., Rivera-Medina, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506223 · Cited by 1,077
Dengue Virus Pathogenesis: an Integrated View
Martina, B. E. E., Koraka, P., & Osterhaus, A. D. M. E. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00035-09 · Cited by 1,053
A Prospective Study of Dengue Infections in Bangkok
Burke, D. S., Nisalak, A., Johnson, D. E., & Scott, R. M. (1988) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.172 · Cited by 828
Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy
Sridhar, S., Luedtke, A., Langevin, E., Zhu, M., Bonaparte, M., Machabert, T., Savarino, S., Zambrano, B., Moureau, A., Khromava, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800820 · Cited by 783
Libraty, D. H., Young, P. R., Pickering, D., Endy, T. P., Kalayanarooj, S., Green, S., Vaughn, D. W., Nisalak, A., Ennis, F. A., & Rothman, A. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/343813 · Cited by 739
Guzman, M. G., Alvarez, M., & Halstead, S. B. (2013) · Archives of Virology · doi:10.1007/s00705-013-1645-3 · Cited by 738
Origins of Dengue Type 2 Viruses Associated with Increased Pathogenicity in the Americas
Rico-Hesse, R., Harrison, L. M., Salas, R. A., Tovar, D., Nisalak, A., Ramos, C., Boshell, J., de Mesa, M. T. R., Nogueira, R. M. R., & Rosa, A. T. D. (1997) · Virology · doi:10.1006/viro.1997.8504 · Cited by 681
Dengue Virus Structural Differences That Correlate with Pathogenesis
Leitmeyer, K. C., Vaughn, D. W., Watts, D. M., Salas, R., Villalobos, I., de Chacon, Ramos, C., & Rico-Hesse, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4738-4747.1999 · Cited by 622
Halstead, S. B., Nimmannitya, S., & Cohen, S. N. (1970) · PubMed Central · Cited by 572
Muller, D. A., & Young, P. R. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.008 · Cited by 572
Modhiran, N., Watterson, D., Muller, D. A., Panetta, A. K., Sester, D. P., Liu, L., Hume, D. A., Stacey, K. J., & Young, P. R. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3863 · Cited by 549
Weaver, S. C., & Vasilakis, N. (2009) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2009.02.003 · Cited by 531
Avirutnan, P., Punyadee, N., Noisakran, S., Komoltri, C., Thiemmeca, S., Auethavornanan, K., Jairungsri, A., Kanlaya, R., Tangthawornchaikul, N., Puttikhunt, C., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/500949 · Cited by 509
Libraty, D. H., Endy, T. P., Houng, H. H., Green, S., Kalayanarooj, S., Suntayakorn, S., Chansiriwongs, W., Vaughn, D. W., Nisalak, A., Ennis, F. A., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/340365 · Cited by 494
Aedes albopictus in North America: Probable Introduction in Used Tires from Northern Asia
Hawley, W. A., Reiter, P., Copeland, R. S., Pumpuni, C. B., & Craig, G. B. (1987) · Science · doi:10.1126/science.3576225 · Cited by 486
MACKENZIE, J. M., JONES, M. K., & YOUNG, P. R. (1996) · Virology · doi:10.1006/viro.1996.0307 · Cited by 454
Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion.
Halstead, S. B. (1970) · PubMed Central · Cited by 428
Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness
Manokaran, G., Finol, E., Wang, C., Gunaratne, J., Bahl, J., Ong, E. Z., Tan, H. C., Sessions, O. M., Ward, A. M., Gubler, D. J., et al. (2015) · Science · doi:10.1126/science.aab3369 · Cited by 412
Halstead, S. B., Mahalingam, S., Marovich, M. A., Ubol, S., & Mosser, D. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70166-3 · Cited by 409
Immunopathological mechanisms in dengue and dengue hemorrhagic fever
Green, S., & Rothman, A. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000244047.31135.fa · Cited by 389
Dengue Virus NS1 Disrupts the Endothelial Glycocalyx, Leading to Hyperpermeability
Puerta-Guardo, H., Glasner, D. R., & Harris, E. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005738 · Cited by 384
Avirutnan, P., Malasit, P., Seliger, B., Bhakdi, S., & Husmann, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6338 · Cited by 377
Green, S., Vaughn, D. W., Kalayanarooj, S., Nimmannitya, S., Suntayakorn, S., Nisalak, A., Lew, R., Innis, B. L., Kurane, I., Rothman, A. L., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314680 · Cited by 371
Bozza, F. A., Cruz, O. G., Zagne, S. M., Azeredo, E. L., Nogueira, R. M., Assis, E. F., Bozza, P. T., & Kubelka, C. F. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-86 · Cited by 367
Goncalvez, A. P., Engle, R. E., St. Claire, M., Purcell, R. H., & Lai, C.-J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703498104 · Cited by 364
Nimmannitya, S., Halstead, S. B., Cohen, S. N., & Margiotta, M. R. (1969) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1969.18.954 · Cited by 358
Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes
Klenerman, P., & Zinkernagel, R. M. (1998) · Nature · doi:10.1038/28860 · Cited by 348
Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis
Chaturvedi, U. (2000) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(00)00163-2 · Cited by 322
Epidemiologic Studies on Dengue in Santiago de Cuba, 1997
Guzman, M. G. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.9.793 · Cited by 320
Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever
Watts, D. M., Porter, K. R., Putvatana, P., Vasquez, B., Calampa, C., Hayes, C. G., & Halstead, S. B. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04015-5 · Cited by 306
Noncoding Flavivirus RNA Displays RNA Interference Suppressor Activity in Insect and Mammalian Cells
Schnettler, E., Sterken, M. G., Leung, J. Y., Metz, S. W., Geertsema, C., Goldbach, R. W., Vlak, J. M., Kohl, A., Khromykh, A. A., & Pijlman, G. P. (2012) · Journal of Virology · doi:10.1128/jvi.01104-12 · Cited by 299
Flavivirus NS1: a multifaceted enigmatic viral protein
Rastogi, M., Sharma, N., & Singh, S. K. (2016) · Virology Journal · doi:10.1186/s12985-016-0590-7 · Cited by 298
Falconar, A. K. I. (1997) · Archives of Virology · doi:10.1007/s007050050127 · Cited by 296
Pathogenesis of vascular leak in dengue virus infection
Malavige, G. N., & Ogg, G. S. (2017) · Immunology · doi:10.1111/imm.12748 · Cited by 285
Dengue Hemorrhagic Fever in Infants: A Study of Clinical and Cytokine Profiles
Hung, N. T., Lei, H., Lan, N. T., Lin, Y., Huang, K., Lien, L. B., Lin, C., Yeh, T., Ha, D. Q., Huong, V. T. Q., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/380762 · Cited by 282
Pang, T., Cardosa, M. J., & Guzman, M. G. (2007) · Immunology & Cell Biology · doi:10.1038/sj.icb.7100008 · Cited by 272
Dengue burden in India: recent trends and importance of climatic parameters
Mutheneni, S. R., Morse, A. P., Caminade, C., & Upadhyayula, S. M. (2017) · Emerging Microbes & Infections · doi:10.1038/emi.2017.57 · Cited by 268
The Structural Basis of Pathogenic Subgenomic Flavivirus RNA (sfRNA) Production
Chapman, E. G., Costantino, D. A., Rabe, J. L., Moon, S. L., Wilusz, J., Nix, J. C., & Kieft, J. S. (2014) · Science · doi:10.1126/science.1250897 · Cited by 259
Understanding the contribution of cellular immunity to dengue disease pathogenesis
Mathew, A., & Rothman, A. L. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00678.x · Cited by 241
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
Ferguson, N. M., Rodríguez-Barraquer, I., Dorigatti, I., Mier-y-Teran-Romero, L., Laydon, D. J., & Cummings, D. A. T. (2016) · Science · doi:10.1126/science.aaf9590 · Cited by 238
Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks
Guzmán, M. G., Kourí, G., Valdés, L., Bravo, J., Vázquez, S., & Halstead, S. B. (2002) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892002000400003 · Cited by 234
Selection for Virulent Dengue Viruses Occurs in Humans and Mosquitoes
Cologna, R., Armstrong, P. M., & Rico-Hesse, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.853-859.2005 · Cited by 228
Kinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K., Takaki, H., Himeno, K., Takaesu, G., Kobayashi, T., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052333 · Cited by 225
Glasner, D. R., Puerta-Guardo, H., Beatty, P. R., & Harris, E. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041848 · Cited by 223
RNA Structures Required for Production of Subgenomic Flavivirus RNA
Funk, A., Truong, K., Nagasaki, T., Torres, S., Floden, N., Balmori Melian, E., Edmonds, J., Dong, H., Shi, P.-Y., & Khromykh, A. A. (2010) · Journal of Virology · doi:10.1128/jvi.01159-10 · Cited by 221
Innate Immunity to Dengue Virus Infection and Subversion of Antiviral Responses
Green, A. M., Beatty, P. R., Hadjilaou, A., & Harris, E. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.11.023 · Cited by 219
Lin, C.-F., Lei, H.-Y., Shiau, A.-L., Liu, H.-S., Yeh, T.-M., Chen, S.-H., Liu, C.-C., Chiu, S.-C., & Lin, Y.-S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.657 · Cited by 210
Anderson, K. B., Gibbons, R. V., Cummings, D. A. T., Nisalak, A., Green, S., Libraty, D. H., Jarman, R. G., Srikiatkhachorn, A., Mammen, M. P., Darunee, B., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit436 · Cited by 209
Antibody-Dependent Enhancement of Ebola Virus Infection
Takada, A., Feldmann, H., Ksiazek, T. G., & Kawaoka, Y. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7539-7544.2003 · Cited by 206
Early CD69 Expression on Peripheral Blood Lymphocytes from Children with Dengue Hemorrhagic Fever
Green, S., Pichyangkul, S., Vaughn, D. W., Kalayanarooj, S., Nimmannitya, S., Nisalak, A., Kurane, I., Rothman, A. L., & Ennis, F. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/315072 · Cited by 205
AEDES AEGYPTI VECTORIAL CAPACITY IS DETERMINED BY THE INFECTING GENOTYPE OF DENGUE VIRUS
ANDERSON, J. R., & RICO-HESSE, R. (2006) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.75.886 · Cited by 204
Differential Targeting of Viral Components by CD4+versus CD8+T Lymphocytes in Dengue Virus Infection
Rivino, L., Kumaran, E. A. P., Jovanovic, V., Nadua, K., Teo, E. W., Pang, S. W., Teo, G. H., Gan, V. C. H., Lye, D. C., Leo, Y. S., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02675-12 · Cited by 203
Moon, S. L., Anderson, J. R., Kumagai, Y., Wilusz, C. J., Akira, S., Khromykh, A. A., & Wilusz, J. (2012) · RNA · doi:10.1261/rna.034330.112 · Cited by 202
Loke, H., Bethell, D., Phuong, C. X. T., Day, N., White, N., Farrar, J., & Hill, A. (2002) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2002.67.102 · Cited by 202
Duyen, H. T. L., Ngoc, T. V., Ha, D. T., Hang, V. T. T., Kieu, N. T. T., Young, P. R., Farrar, J. J., Simmons, C. P., Wolbers, M., & Wills, B. A. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir014 · Cited by 199
Ubol, S., Phuklia, W., Kalayanarooj, S., & Modhiran, N. (2010) · The Journal of Infectious Diseases · doi:10.1086/651018 · Cited by 196
Human T Cell Response to Dengue Virus Infection
Tian, Y., Grifoni, A., Sette, A., & Weiskopf, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02125 · Cited by 180
Dengue Virus Selectively Induces Human Mast Cell Chemokine Production
King, C. A., Anderson, R., & Marshall, J. S. (2002) · Journal of Virology · doi:10.1128/jvi.76.16.8408-8419.2002 · Cited by 174
Roby, J., Pijlman, G., Wilusz, J., & Khromykh, A. (2014) · Viruses · doi:10.3390/v6020404 · Cited by 170
Lin, C.-F., Chiu, S.-C., Hsiao, Y.-L., Wan, S.-W., Lei, H.-Y., Shiau, A.-L., Liu, H.-S., Yeh, T.-M., Chen, S.-H., Liu, C.-C., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.395 · Cited by 167
Immunological enhancement of dengue virus replication.
Halstead, S. B., Chow, J. S., & Marchette, N. J. (1973) · PubMed · Cited by 162
Duong, V., Ly, S., Try, P. L., Tuiskunen, A., Ong, S., Chroeung, N., Lundkvist, Å., Leparc-Goffart, I., Deubel, V., Vong, S., et al. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001244 · Cited by 152
How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections
Ubol, S., & Halstead, S. B. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00316-10 · Cited by 151
Ubol, S., Masrinoul, P., Chaijaruwanich, J., Kalayanarooj, S., Charoensirisuthikul, T., & Kasisith, J. (2008) · The Journal of Infectious Diseases · doi:10.1086/587699 · Cited by 146
Dengue NS1 antigen as a marker of severe clinical disease
Paranavitane, S. A., Gomes, L., Kamaladasa, A., Adikari, T. N., Wickramasinghe, N., Jeewandara, C., Shyamali, N. L. A., Ogg, G. S., & Malavige, G. N. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0570-8 · Cited by 139
Chen, H., Chuang, Y., Lin, Y.-S., Liu, H., Liu, C., Perng, G., & Yeh, T. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004828 · Cited by 139
Perez, A. B., Sierra, B., García, G., Aguirre, E., Babel, N., Álvarez, M., Sanchez, L., Valdés, L., Volk, H., & Guzmán, M. G. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.08.004 · Cited by 133
Neutralizing Antibodies after Infection with Dengue 1 Virus
Guzman, M. G., Alvarez, M., Rodriguez-Roche, R., Bernardo, L., Montes, T., Vazquez, S., Morier, L., Alvarez, A., Gould, E. A., Kourí, G., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1302.060539 · Cited by 122
Recent advances in understanding dengue
Halstead, S. B. (2019) · F1000Research · doi:10.12688/f1000research.19197.1 · Cited by 118
An Explosive Epidemic of DENV-3 in Cairns, Australia
Ritchie, S. A., Pyke, A. T., Hall‐Mendelin, S., Day, A., Mores, C. N., Christofferson, R. C., Gubler, D. J., Bennett, S. N., & van den Hurk, A. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068137 · Cited by 105
LaFleur, C., Granados, J., Vargas-Alarcon, G., Ruíz-Morales, J., Villarreal-Garza, C., Higuera, L., Hernández-Pacheco, G., Cutiño-Moguel, T., Rangel, H., Figueroa, R., et al. (2002) · Human Immunology · doi:10.1016/s0198-8859(02)00682-1 · Cited by 103
Potential of ancestral sylvatic dengue-2 viruses to re-emerge
Vasilakis, N., Shell, E. J., Fokam, E. B., Mason, P. W., Hanley, K. A., Estes, D. M., & Weaver, S. C. (2006) · Virology · doi:10.1016/j.virol.2006.08.049 · Cited by 100
Autoimmunity in dengue pathogenesis
Wan, S.-W., Lin, C., Yeh, T., Liu, C., Liu, H., Wang, S., Ling, P., Anderson, R., Lei, H.-Y., & Lin, Y.-S. (2012) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2012.11.006 · Cited by 98
Garcı́a, G., Sierra, B., Pérez, A. B., Aguirre, E., Rosado, I., González, N., Izquierdo, A., Pupo, M., Díaz, D. R. D., Sánchez, L., et al. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.09-0353 · Cited by 97
Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients
Ouyang, X., Jiang, X. J., Gu, D., Zhang, Y., Kong, S. K., Jiang, C.-X., & Xie, W. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.13996 · Cited by 96
An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection
Tsai, T., Chuang, Y.-J., Lin, Y.-S., Wan, S.-W., Chen, C., & Lin, C. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-40 · Cited by 93
Do escape mutants explain rapid increases in dengue casefatality rates within epidemics?
Guzmán, M. G., Kourí, G., & Halstead, S. B. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02303-5 · Cited by 92
Chang, R.-Y., Hsu, T.-W., Chen, Y., Liu, S.-F., Tsai, Y.-J., Lin, Y.-T., Chen, Y.-S., & Fan, Y.-H. (2013) · Veterinary Microbiology · doi:10.1016/j.vetmic.2013.04.026 · Cited by 92
Recent advances in dengue pathogenesis and clinical management
Simmons, C. P., McPherson, K., Châu, N. V. V., Tam, D. T. H., Young, P. R., Mackenzie, J. M., & Wills, B. A. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.103 · Cited by 89
Progress towards understanding the pathogenesis of dengue hemorrhagic fever
Pang, X., Zhang, R., & Cheng, G. (2016) · Virologica Sinica · doi:10.1007/s12250-016-3855-9 · Cited by 88
Hernández, S. I. D. L. C., Flores-Aguilar, H., González-Mateos, S., López-Martı́nez, I., Alpuche-Aranda, C. M., Ludert, J. E., & del Angel, R. M. (2013) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.12-0023 · Cited by 82
MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2
Cheng, Z.-S., Ma, R., Tan, W.-J., & Zhang, L. (2014) · Experimental and Molecular Medicine · doi:10.1038/emm.2014.51 · Cited by 78
Soundravally, R., & Hoti, S. L. (2007) · Human Immunology · doi:10.1016/j.humimm.2007.09.007 · Cited by 73
Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation
Suresh, R., Chandrasekaran, P., Sutterwala, F. S., & Mosser, D. M. (2016) · Journal of Cell Science · doi:10.1242/jcs.179291 · Cited by 73
Wan, S.-W., Lu, Y., Huang, C.-H., Lin, C., Anderson, R., Liu, H., Yeh, T., Yen, Y.-T., Wu‐Hsieh, B. A., & Lin, Y.-S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092495 · Cited by 72
Host genetic susceptibility to severe dengue infection
Lan, N. T. P., & Hirayama, K. (2011) · Tropical Medicine and Health · doi:10.2149/tmh.2011-s08 · Cited by 71
The Complement System in Flavivirus Infections
Conde, J. N., Silva, E. M., Barbosa, A. S., & Mohana‐Borges, R. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00213 · Cited by 71
Molecular epidemiology and evolution of emerging infectious diseases
Holmes, E. C. (1998) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011708 · Cited by 69
How Dengue Virus Circumvents Innate Immunity
Kao, Y.-T., Lai, M. M. C., & Yu, C.-Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02860 · Cited by 67
Chymase Level Is a Predictive Biomarker of Dengue Hemorrhagic Fever in Pediatric and Adult Patients
Tissera, H. A., Rathore, A. P. S., Leong, W. Y., Pike, B. L., Warkentien, T. E., Farouk, F. S., Syenina, A., Ooi, E. E., Gubler, D. J., Wilder‐Smith, A., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix447 · Cited by 64
Dengue Virus Replication Enhancement in Peripheral Blood Leukocytes from Immune Human Beings
Halstead, S. B., Marchette, N. J., Chow, J. S., & Lolekha, S. (1976) · Experimental Biology and Medicine · doi:10.3181/00379727-151-39160 · Cited by 63
Chuang, Y., Lin, J., Lin, Y.-S., Wang, S., & Yeh, T. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500057 · Cited by 59
Meta-analysis of biomarkers for severe dengue infections
Soo, K.-M., Khalid, B., Ching, S. M., Tham, C. L., Basir, R., & Chee, H. (2017) · PeerJ · doi:10.7717/peerj.3589 · Cited by 56
Punyadee, N., Mairiang, D., Thiemmeca, S., Komoltri, C., Ngum, W. P., Chomanee, N., Charngkaew, K., Tangthawornchaikul, N., Limpitikul, W., Vasanawathana, S., et al. (2014) · Journal of Virology · doi:10.1128/jvi.02207-14 · Cited by 53
Advances in the understanding, management, and prevention of dengue
Hermann, L. L., Gupta, S. B., Manoff, S. B., Kalayanarooj, S., Gibbons, R. V., & Coller, B.-A. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.08.031 · Cited by 52
Chen, H., Lin, S.-R., Liu, H., King, C., Hsieh, S., & Wang, W.-K. (2008) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2008.79.495 · Cited by 52
Evaluation of Dengue Virus strains for human challenge studies
Mammen, M. P., Lyons, A. G., Innis, B. L., Sun, W., McKinney, D., Chung, R. C. Y., Eckels, K. H., Putnak, R. J., Kanesa-thasan, N., Scherer, J. M., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.12.040 · Cited by 48
RNA viruses and microRNAs: challenging discoveries for the 21st century
Swaminathan, G., Martín‐García, J., & Navas, S. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00112.2013 · Cited by 46
Chuang, Y., Wang, S., Lin, Y.-S., Chen, H., & Yeh, T. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-42 · Cited by 45
Virus Role During Intraepidemic Increase in Dengue Disease Severity
Rodríguez, R., Sánchez, L., Burgher, Y., Rosario, D., Álvarez, M., Kourí, G., Halstead, S. B., Gould, E. A., & Guzmán, M. G. (2011) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2010.0177 · Cited by 42
Denguevirus-specific suppressor T cells: current perspectives
Chaturvedi, U. C., Shrivastava, R., Tripathi, R. K., & Nagar, R. (2007) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2007.00273.x · Cited by 31
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
Sehrawat, P., Biswas, A., Kumar, P., Singla, P., Wig, N., Dar, L., & Sood, R. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.023 · Cited by 30
Martínez-Vega, R. A., Carrasquila, G., Luna, E. J. D. A., & Ramos‐Castañeda, J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.06.004 · Cited by 29
Mehta, V., Verma, R. K., Garg, R. K., Malhotra, H., Sharma, P., & Jain, A. (2016) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.188545 · Cited by 23
Immunological considerations for developing antibody therapeutics for Influenza A
Chan-Hui, P.-Y., & Swiderek, K. M. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1079676 · Cited by 13
Metadata
- Authors
- Bhatt, P., Sabeena, S. P., Varma, M., & Arunkumar, G.
- Venue
- Current Microbiology
- Published
- 2020-11-24
- Volume
- 78
- Issue
- 1
- Pages
- 17-32
- ISSN
- 0343-8651 (ISSN-L)
- 1432-0991
- OpenAlex
- W3107339967
- Cited by
- 378
- References
- 109
- FWCI
- 22.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.